Wednesday, 19 February 2020

Japan News

  • APAC ovarian cancer drug market to grow modestly'

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more

  • Agenix gets patent for ThromboView in Japan

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Japan's Patent Office has granted a key patent to drug and diagnostic company Agenix covering the manufacturing process of its ThromboView imaging agent for the detection of bloo...Read more

  • Deal with Janssen gets Astellas $65 million up-front

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2012

    Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to develop and commercialize ASP015K, an Astellas compound, worldwide e...Read more

  • Scil Proteins, Ono collaborate to develop Affilin therapeutics

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Scil Proteins, a private biotech company specializing in the research, development and production of recombinant proteins, has signed a collaboration agreement with Ono Pharmaceu...Read more

  • Takeda acquires URL Pharma

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2012

    Singapore: Takeda Pharmaceutical Company acquired URL Pharma through its wholly-owned subsidiary Takeda America Holdings (TAH), for an upfront payment of $800 million in cash and future per...Read more

  • Lorcaserin receives positive vote from FDA advisory committee

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to four, with one abstention, at a meeting held on ...Read more

  • Genetic diagnostics companies speed ahead

    Japan |  Opinion | By Nandita Singh | 0 Comment | 28 Jun, 2013

    The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US Supreme Court on June 13, 2013, stating that human genes cannot be p...Read more

  • Amgen CEO speaks of firm's grand entry into Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    The world's largest biotechnology company Amgen entered into a long-term collaboration with Astellas Pharma in May this year, and is set to form a joint venture in Tokyo, Amgen Astellas Bio...Read more